David E Portlock

Title: The Innovations of David E Portlock

Introduction

David E Portlock is a notable inventor based in Norwich, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as angiotensin I converting enzyme inhibitors. With a total of three patents to his name, Portlock's work has had a meaningful impact on medical science.

Latest Patents

Portlock's latest patents include a series of compounds, specifically 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids and salts thereof, which are recognized for their utility as angiotensin I converting enzyme inhibitors. Another significant patent is for the compound (3-Mercapto-1-oxopropyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic, which also serves as an angiotensin I converting enzyme inhibitor. These innovations highlight his commitment to advancing pharmaceutical research.

Career Highlights

Throughout his career, Portlock has worked with several prominent companies, including Norwich Eaton Pharmaceuticals, Inc. and Morton-Norwich Products, Inc. His experience in these organizations has allowed him to refine his skills and contribute to important projects in the pharmaceutical industry.

Collaborations

One of Portlock's notable collaborators is Ralph L White, Jr. Their partnership has likely fostered innovative ideas and advancements in their respective fields.

Conclusion

David E Portlock's contributions to pharmaceutical innovation through his patents and collaborations underscore his importance as an inventor. His work continues to influence the development of critical medical treatments.